Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epidermodysplasia verruciformis.

D Dyall-Smith1, P Cowen, G Varigos

  • 1Repatriation General Hospital, Heidelberg, Victoria.

The Australasian Journal of Dermatology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study.

The British journal of dermatology·2017
Same author

Mastocytosis: a case series of 107 consecutive patients.

The British journal of dermatology·2017
Same author

Automated colour identification in melanocytic lesions.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2016
Same author

Withdrawn: An unusual urticarial eruption: familial cold autoinflammatory syndrome.

Australian dental journal·2015
Same author

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.

Psychological medicine·2014
Same author

Five patients with melanosis of the nipple and areola clinically mimicking melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2013

Epidermodysplasia verruciformis, a rare genetic disorder, presents challenging skin lesions and squamous cell carcinomas. Despite extensive treatment over ten years, the patient experienced relentless disease progression, highlighting management difficulties.

Area of Science:

  • Dermatology
  • Genetics
  • Oncology

Background:

  • Epidermodysplasia verruciformis (EV) is a rare, inherited disorder characterized by extreme susceptibility to specific human papillomaviruses (HPVs).
  • EV predisposes individuals to non-melanoma skin cancers, primarily squamous cell carcinomas (SCCs), often leading to reduced lifespan due to metastatic disease.
  • Management of EV is challenging due to the widespread and persistent nature of HPV infections and associated malignancies.

Observation:

  • A ten-year longitudinal study of a single patient diagnosed with epidermodysplasia verruciformis.
  • The diagnosis was confirmed via high-stringency nucleic acid hybridization to cloned human papillomavirus DNA.
  • The patient exhibited relentless progression of the disease despite a range of intensive therapeutic interventions.

Findings:

Related Experiment Videos

  • Confirmation of epidermodysplasia verruciformis diagnosis using molecular techniques (nucleic acid hybridization).
  • Demonstration of disease persistence and progression despite aggressive and varied treatment modalities over a decade.
  • The case underscores the inherent difficulty in managing advanced epidermodysplasia verruciformis.

Implications:

  • Highlights the limited efficacy of current treatments for advanced epidermodysplasia verruciformis.
  • Emphasizes the critical need for novel therapeutic strategies and improved management protocols for this rare genetic disorder.
  • Suggests further research into the oncogenic pathways of human papillomavirus in the context of genetic predisposition.